{"id":767,"date":"2022-09-13T17:18:16","date_gmt":"2022-09-13T17:18:16","guid":{"rendered":"https:\/\/radparts.com\/cpswp\/?p=767"},"modified":"2022-09-14T14:30:39","modified_gmt":"2022-09-14T14:30:39","slug":"particle-accelerators-create-potential-cancer-treatment-in-lansing","status":"publish","type":"post","link":"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/","title":{"rendered":"Particle Accelerators Create Potential Cancer Treatment in Lansing"},"content":{"rendered":"

A Lansing company called Niowave has begun producing actinium-225, a silvery metal isotope that barely exists on Earth, with a superconducting linear accelerator. The reason? This isotope is a promising cancer treatment; however, researchers don\u2019t know its full potential due to the absence of clinical trials.<\/p>\n

Niowave has secured a $5 million deal with Fusion Pharmaceuticals to start production in 2024.\u00a0 Between Russia, the United States, Germany, and Canada, there are only two curies (unit of measurement for radioactive materials) of actinium-225. Niowave plans on making one curie per week.<\/p>\n

In 2019, the federal government gave Niowave $15 million, and another $13 million last year, to produce molybdenum 99, which is used for medical imaging. Since other countries subsidize its production, making a profit from molybdenum 99 is tricky.<\/p>\n

After working with uranium for years, the federal government determined Niowave could function safely with another highly radioactive element, radium, to create actinium-225.<\/p>\n

Cancer therapy isotopes emit beta particles, which can destroy cancer cells but also kill healthy cells around them. Actinium-225 delivers more targeted alpha particles, which can emit more energy at a shorter distance.<\/p>\n

Justin Wilson, an associate professor of chemistry and chemical biology at Cornell University said, \u201cIf you can get those alpha particles to the cancer cells, they have the capability of doing more damage but in a more confined region. Which, in theory, could prevent hitting healthy cells that maybe aren\u2019t part of the small metastatic lesion.\u201d<\/p>\n

Eric Burak, chief technical officer at Fusion Pharmaceuticals, states that they are working on formulating three separate drugs that use actinium-225. He said the isotope is \u201cOne of the rarest elements in the entire planet, and, with more companies interested in its therapeutic potential, everyone is scrambling for actinium supply.\u201d<\/p>\n

Fusion Pharmaceuticals are investing $5 million to help Niowave create actinium-225 in exchange for a guaranteed share of the end result.<\/p>\n

Niowave\u2019s superconducting linear accelerator has been moved to a concrete room as radium is extremely radioactive.<\/p>\n

_______________________________<\/p>\n

RadParts<\/a> is the world\u2019s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerator and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost parts and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838<\/a> to learn more.<\/p>\n

 <\/p>\n

Written by the digital marketing team at Creative Programs & Systems: <\/em>https:\/\/www.cpsmi.com\/<\/em><\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

A Lansing company called Niowave has begun producing actinium-225, a silvery metal isotope that barely exists on Earth, with a superconducting linear accelerator. The reason? This isotope is a promising cancer treatment; however, researchers don\u2019t know its full potential due to the absence of clinical trials. Niowave has secured a $5 million deal with Fusion … Continue reading “Particle Accelerators Create Potential Cancer Treatment in Lansing”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-767","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nParticle Accelerators Create Potential Cancer Treatment in Lansing - RadParts<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Particle Accelerators Create Potential Cancer Treatment in Lansing - RadParts\" \/>\n<meta property=\"og:description\" content=\"A Lansing company called Niowave has begun producing actinium-225, a silvery metal isotope that barely exists on Earth, with a superconducting linear accelerator. The reason? This isotope is a promising cancer treatment; however, researchers don\u2019t know its full potential due to the absence of clinical trials. Niowave has secured a $5 million deal with Fusion … Continue reading "Particle Accelerators Create Potential Cancer Treatment in Lansing"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/\" \/>\n<meta property=\"og:site_name\" content=\"RadParts\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-13T17:18:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-14T14:30:39+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/\",\"url\":\"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/\",\"name\":\"Particle Accelerators Create Potential Cancer Treatment in Lansing - RadParts\",\"isPartOf\":{\"@id\":\"https:\/\/radparts.com\/cpswp\/#website\"},\"datePublished\":\"2022-09-13T17:18:16+00:00\",\"dateModified\":\"2022-09-14T14:30:39+00:00\",\"author\":{\"@id\":\"https:\/\/radparts.com\/cpswp\/#\/schema\/person\/b712ac7bfd90eaf1dc8f94ba8908025d\"},\"breadcrumb\":{\"@id\":\"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/radparts.com\/cpswp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Particle Accelerators Create Potential Cancer Treatment in Lansing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/radparts.com\/cpswp\/#website\",\"url\":\"https:\/\/radparts.com\/cpswp\/\",\"name\":\"RadParts\",\"description\":\"www.radparts.com\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/radparts.com\/cpswp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/radparts.com\/cpswp\/#\/schema\/person\/b712ac7bfd90eaf1dc8f94ba8908025d\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/radparts.com\/cpswp\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7cdb04109561683a8c0fbc2f7d5b632b8195dcb4c0c1b7461942dfc08c4f15ac?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7cdb04109561683a8c0fbc2f7d5b632b8195dcb4c0c1b7461942dfc08c4f15ac?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/radparts.com\/cpswp\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Particle Accelerators Create Potential Cancer Treatment in Lansing - RadParts","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/","og_locale":"en_US","og_type":"article","og_title":"Particle Accelerators Create Potential Cancer Treatment in Lansing - RadParts","og_description":"A Lansing company called Niowave has begun producing actinium-225, a silvery metal isotope that barely exists on Earth, with a superconducting linear accelerator. The reason? This isotope is a promising cancer treatment; however, researchers don\u2019t know its full potential due to the absence of clinical trials. Niowave has secured a $5 million deal with Fusion … Continue reading \"Particle Accelerators Create Potential Cancer Treatment in Lansing\"","og_url":"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/","og_site_name":"RadParts","article_published_time":"2022-09-13T17:18:16+00:00","article_modified_time":"2022-09-14T14:30:39+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/","url":"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/","name":"Particle Accelerators Create Potential Cancer Treatment in Lansing - RadParts","isPartOf":{"@id":"https:\/\/radparts.com\/cpswp\/#website"},"datePublished":"2022-09-13T17:18:16+00:00","dateModified":"2022-09-14T14:30:39+00:00","author":{"@id":"https:\/\/radparts.com\/cpswp\/#\/schema\/person\/b712ac7bfd90eaf1dc8f94ba8908025d"},"breadcrumb":{"@id":"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/radparts.com\/cpswp\/uncategorized\/particle-accelerators-create-potential-cancer-treatment-in-lansing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/radparts.com\/cpswp\/"},{"@type":"ListItem","position":2,"name":"Particle Accelerators Create Potential Cancer Treatment in Lansing"}]},{"@type":"WebSite","@id":"https:\/\/radparts.com\/cpswp\/#website","url":"https:\/\/radparts.com\/cpswp\/","name":"RadParts","description":"www.radparts.com","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/radparts.com\/cpswp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/radparts.com\/cpswp\/#\/schema\/person\/b712ac7bfd90eaf1dc8f94ba8908025d","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/radparts.com\/cpswp\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7cdb04109561683a8c0fbc2f7d5b632b8195dcb4c0c1b7461942dfc08c4f15ac?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7cdb04109561683a8c0fbc2f7d5b632b8195dcb4c0c1b7461942dfc08c4f15ac?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/radparts.com\/cpswp\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/posts\/767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/comments?post=767"}],"version-history":[{"count":2,"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/posts\/767\/revisions"}],"predecessor-version":[{"id":769,"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/posts\/767\/revisions\/769"}],"wp:attachment":[{"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/media?parent=767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/categories?post=767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/radparts.com\/cpswp\/wp-json\/wp\/v2\/tags?post=767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}